 This is a pilot research study examining the use of varenicline Chantix and the nicotine patch. The study is designed to find out whether one of these medications is more effective for smoking cessation with head and neck cancer patients. The study has three parts: 1 two intake sessions; 2 an 8-week treatment phase, and 3 a 3-month follow-up. 